FK228,
FR 901228,
FR-901228,
FR901228,
istodax,
romidepsin,
Romidepsin,
Istodax,
FK228,
Chromadax,
Antibiotic FR 901228,
Depsipeptide,
FR901228,
128517-07-7,
FR-901228,
NSC-630176,
FK-228,
C24H36N4O6S2,
FR 901228,
FK 228,
CHEMBL343448,
CHEBI:61080,
NSC630176,
NSC754143,
UNII-CX3T89XQBK,
NSC 630176,
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone,
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone,
(1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone,
Istodax (TN),
CX3T89XQBK,
HDInhib_000006,
romidepsina,
romidepsine,
romidepsinum,
OXA-12,8,20,23-TETRAZABICYCLO[8.7.6]TRICOSANE, CYCLIC PEPTIDE DERIV.,
(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo(8.7.6)tricos-16-ene-3,6,9,19,22-pentone,
L-Valine, N-((3S,4E)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(2Z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide,
L-Valine, N-(3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(Z)-2,3-didehydro-2-aminobutanoyl-, xi-lactone, cyclic (1-2)-disulfide, (S-(E))-,
FK-901228,
Probes1_000153,
Probes2_000337,
AC1NS1N3,
Romidepsin (JAN/USAN/INN),
SCHEMBL677497,
GTPL7006,
Romidepsin, >=98% (HPLC),
BDBM19151,
AOB1853,
Romidepsin (FK228 ,depsipeptide),
Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl] Cyclic (35)-Disulfide,
ZINC3935130,
2692AH,
MFCD18433404,
s3020,
API0005301,
CS-0985,
NSC-754143,
HY-15149,
LS-161318,
D06637,
W-5757,
49300-EP2298768A1,
49300-EP2311840A1,
AB01273968-01,
SR-01000941579,
SR-01000941579-1,
L-Valine,3-didehydro-2- aminobutanoyl-,.xi.-lactone, cyclic (1.fwdarw.2)-disulfide,
L-Valine,3-didehydro-2-aminobutanoyl-,.xi.-lactone, cyclic (1.fwdarw.2)-disulfide,
(E)-(1S,10S,21R)-7-[(Z)-Ethylidene]-4,21-diisopropyl-2- oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone,
(E)-(1S,10S,21R)-7-[(Z)-Ethylidene]-4,21-diisopropyl-2- oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone,
[S-(E)]-N-(3-Hydroxy-7-mercapto-1-oxo-4-heptenyl)-D-valyl-D-cysteinyl-(Z)-2,3-didehydro-2-aminobutanoyl-L-valine (4-1)-Lactone Cyclic (12)-Disulfide,
Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (3?5)-disulfide",
Chromadax (TN),
Romidepsin (USAN),
Romidepsin [USAN],
Romidepsin [USAN:INN],
D0L7LC,
C24-H36-N4-O6-S2,
CID5352062,
CS-T-61146,
C087123,
Romidepsin, 98%, a potent HDAC1 and HDAC2 inhibitor - 1MG 1mg,
Cyclo((2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl), cyclic (35)-disulfide,
Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl], cyclic (35)-disulfide,